Evidence map›Paper›PMID 20505173›Full record

Trial reportThe New England journal of medicine2010

Stenting versus endarterectomy for treatment of carotid-artery stenosis.

Thomas G Brott, Robert W Hobson, George Howard, Gary S Roubin, Wayne M Clark, William Brooks, Ariane Mackey, Michael D Hill, Pierre P Leimgruber, Alice J Sheffet and 15 more

Erratum issued 2 registry-linked trialsOpen access · bronzeAbstract readComparative StudyMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in The New England journal of medicine, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 2 registered trials, which are not on this map. Cited by 770 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
770citing papers in PubMed, 7 pooled it
212.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00004732 nacompletednot on this map

Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST)

TypeinterventionalSponsorRutgers, The State University of New JerseyRan2000 to 2016Enrolled2,502ConditionsAtherosclerosis, Stroke, Carotid Stenosis, Cerebral InfarctionArmsCarotid Endarterectomy (CEA), Carotid Artery Stenting (CAS)
NCT06123767 nanot yet recruitingnot on this mapstarted 2024, after this paper: background citation

Evaluation of Diagnostic and Predictive Capabilities of Novel Application of Carotid Carotid Stenosis Pressure Gradient Measurement in Patients Undergoing Percutaneous Carotid Angioplasty and Stenting (CAS).

TypeinterventionalSponsor4th Military Clinical Hospital with Polyclinic, PolandRan2024 to 2027Enrolled200ConditionsCarotid Artery Stenosis, Carotid Artery Stenting, StrokeArmsCAS + Intravascular measuring the pressure gradient, CAS (standard), Doppler ultrasonound of cephalic arteries, Angio-CT of the neck and head, Otolaryngological examination
3 · Its place in the literature

Who cites it

770 citing papers in PubMed, 7 syntheses or guidelines pooled it, 2,963 citations in OpenAlex.

  1. Transradial versus transfemoral access in carotid artery stenting: A meta-analysis.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2026
    Pooled it
  2. Pooled it
  3. Carotid Artery Stenting With Double-Layer Stent: A Systematic Review and Meta-Analysis.Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists · 2024
    Pooled it
  4. Guideline
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Carotid artery stenting without embolic protection: A randomized multicenter trial (the CASWEP trial).Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2023
    Trial
  11. Trial
  12. Trial
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. The evolving landscape of stroke interventions.Singapore medical journal · 2026
    Article
  19. Article
  20. Observational

710 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors at 20 institutions in 3 countries.

Thomas G BrottMayo Clinic, Griffin 304, 4500 San Pablo Rd., Jacksonville, FL 32224, USA. brott.thomas@mayo.edu
Robert W Hobson
George Howard
Gary S Roubin
Wayne M Clark
William Brooks
Ariane Mackey
Michael D Hill
Pierre P Leimgruber
Alice J Sheffet
Virginia J Howard
Wesley S Moore
Jenifer H Voeks
L Nelson Hopkins
Donald E Cutlip
David J Cohen
Jeffrey J Popma
Robert D Ferguson
Stanley N Cohen
Joseph L Blackshear
Frank L Silver
J P Mohr
Brajesh K Lal
James F Meschia
CREST Investigators
University of Alabama at Birmingham · USBaim Institute for Clinical Research · USCentral Baptist Hospital · USColumbia University Irving Medical Center · USHadassah Medical Center · ILHôpital de l'Enfant-Jésus · CAJacksonville College · USLas Vegas Institute · USLenox Hill Hospital · USMayo Clinic in Florida · USMetroHealth · USOregon Health & Science University · USSaint Luke's Hospital · USUCLA Health · USUniversity at Buffalo, State University of New York · USUniversity Hospital, Newark · USUniversity of Calgary · CAUniversity of Maryland Medical Center · USUniversity of Toronto · CAWinnMed · US

Funding

Carotid Revascularization Endarterectomy vs Stenting TrialR01NS038384 · NINDS · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI BROTT, THOMAS G · 1999 to 2010
$40.7M
Carotid Revascularization Endarterectomy vs. Stenting Trial: Long Term Follow-upU01NS038384 · NINDS · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI BROTT, THOMAS G, SHEFFET, ALICE J · 2011 to 2016
$15.4M
Medical Research Council G0500495NINDS NIH HHS R01 NS 038384NINDS NIH HHS R01 NS038384NINDS NIH HHS U01 NS038384
6 · The paper itself

Abstract

backgroundCarotid-artery stenting and carotid endarterectomy are both options for treating carotid-artery stenosis, an important cause of stroke.

methodsWe randomly assigned patients with symptomatic or asymptomatic carotid stenosis to undergo carotid-artery stenting or carotid endarterectomy. The primary composite end point was stroke, myocardial infarction, or death from any cause during the periprocedural period or any ipsilateral stroke within 4 years after randomization.

resultsFor 2502 patients over a median follow-up period of 2.5 years, there was no significant difference in the estimated 4-year rates of the primary end point between the stenting group and the endarterectomy group (7.2% and 6.8%, respectively; hazard ratio with stenting, 1.11; 95% confidence interval, 0.81 to 1.51; P=0.51). There was no differential treatment effect with regard to the primary end point according to symptomatic status (P=0.84) or sex (P=0.34). The 4-year rate of stroke or death was 6.4% with stenting and 4.7% with endarterectomy (hazard ratio, 1.50; P=0.03); the rates among symptomatic patients were 8.0% and 6.4% (hazard ratio, 1.37; P=0.14), and the rates among asymptomatic patients were 4.5% and 2.7% (hazard ratio, 1.86; P=0.07), respectively. Periprocedural rates of individual components of the end points differed between the stenting group and the endarterectomy group: for death (0.7% vs. 0.3%, P=0.18), for stroke (4.1% vs. 2.3%, P=0.01), and for myocardial infarction (1.1% vs. 2.3%, P=0.03). After this period, the incidences of ipsilateral stroke with stenting and with endarterectomy were similarly low (2.0% and 2.4%, respectively; P=0.85).

conclusionsAmong patients with symptomatic or asymptomatic carotid stenosis, the risk of the composite primary outcome of stroke, myocardial infarction, or death did not differ significantly in the group undergoing carotid-artery stenting and the group undergoing carotid endarterectomy. During the periprocedural period, there was a higher risk of stroke with stenting and a higher risk of myocardial infarction with endarterectomy. (ClinicalTrials.gov number, NCT00004732.)

Indexed as

Endarterectomy, CarotidStentsAdultAgedAged, 80 and overCarotid StenosisFemaleFollow-Up StudiesHumansMaleMiddle AgedMyocardial InfarctionQuality of LifeStroke

Identifiers

PMID20505173
PMCPMC2932446
OpenAlexW2100194095

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.